Compound class:
Synthetic organic
Comment: eAmSPC 2593 is the lead from a new class of N-ethylene linked aminomethyl spectinomycins (eAmSPCs), discovered following modification of spectinomycin, and with promising antimycobacterial activity [2]. The structure is claimed in patent WO2015048692A1 filed by St. Jude Children's Research Hospital [1].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
(1R,3S,5R,7R,8S,10R,11S,12S,13R,14S)-7-[[2-(4-fluorophenyl)ethylamino]methyl]-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecane-7,8,12,14-tetrol |
Database Links ![]() |
|
Specialist databases | |
Antibiotic DB
![]() |
eAmSPC 2593 |
Other databases | |
CAS Registry No. | 1690343-66-8 (source: Scifinder) |
GtoPdb PubChem SID | 504705384 |
PubChem CID | 117986569 |
Search Google for chemical match using the InChIKey | KRCLSDQUEUBIKY-LLHOOWCXSA-N |
Search Google for chemicals with the same backbone | KRCLSDQUEUBIKY |
UniChem Compound Search for chemical match using the InChIKey | KRCLSDQUEUBIKY-LLHOOWCXSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | KRCLSDQUEUBIKY-LLHOOWCXSA-N |